Diquafosol Tetrasodium

PURPOSE To evaluate the effectiveness of 3% diquafosol tetrasodium for treating dry eye after cataract surgery. METHODS Among… (More)

PURPOSE This study was undertaken to determine the effect of topical application of diquafosol tetrasodium on proteins and mucin… (More)

PURPOSE To evaluate the effect of diquafosol tetrasodium (DQS) for the treatment of persistent dry eye after laser in situ… (More)

PURPOSE To evaluate the possible advantages of combination therapy with diquafosol tetrasodium and sodium hyaluronate for dry eye… (More)

INTRODUCTION Dry eye is a multifactorial disease of the ocular surface causing ocular discomfort and visual impairment for the… (More)

PURPOSE To investigate the effect of diquafosol tetrasodium on tear and visual function in short break-up time (sBUT) dry eye (DE… (More)

PurposeTo assess the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye… (More)

PURPOSE To investigate the safety and efficacy of diquafosol tetrasodium, a P2Y2 receptor agonist that stimulates fluid and mucin… (More)

The ophthalmic formulation of diquafosol tetrasodium (INS365), a P2Y2 receptor agonist, is targeted to treat dry eye disease… (More)

Inspire, in collaboration with Allergan and Santen, is developing an eye-drop formulation of diquafosol tetrasodium (INS-365), a… (More)